Literature DB >> 9560329

Activation of gelatinase-tissue-inhibitors-of-metalloproteinase complexes by matrilysin.

D C von Bredow1, A E Cress, E W Howard, G T Bowden, R B Nagle.   

Abstract

Matrilysin, gelatinase A and gelatinase B are matrix metalloproteinases (MMPs) implicated in normal and pathological processes that require remodelling of the extracellular matrix. In human prostate tissue, matrilysin is synthesized in ducts surrounded by inflammatory cells, and focally in prostate carcinoma, but not in normal glands. Gelatinase B expression is restricted to inflammatory cells. Gelatinase A can be found in both benign and malignant prostate tissue. MMP activities are regulated by their transition from latent to activated forms, as well as by the presence of tissue inhibitors of metalloproteinases (TIMPs). We investigated whether matrilysin can activate progelatinases A and B in the presence of their bound inhibitors TIMP2 and TIMP1 respectively. Incubation of progelatinase B-TIMP1 complex with active matrilysin resulted in 78 and 68 kDa active forms, as measured by SDS-PAGE and enzyme activity assays. TIMP-free gelatinase B was also activated by matrilysin. In addition, activation of progelatinase B by matrilysin was demonstrated in the conditioned medium of phorbol ester-treated HT1080 cells, confirming the results obtained in the in vitro experiments. In contrast, matrilysin did not proteolytically cleave gelatinase A-TIMP2 complex, but led to a transient increase in gelatinolytic activity of the proenzyme. Matrilysin did not enhance the autocatalytic conversion of its own proform. The data presented here suggest that matrilysin participates in a proteolytic cascade and can activate gelatinases in the presence of TIMPs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9560329      PMCID: PMC1219442          DOI: 10.1042/bj3310965

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  61 in total

1.  Regulation of the autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinases-2.

Authors:  E W Howard; E C Bullen; M J Banda
Journal:  J Biol Chem       Date:  1991-07-15       Impact factor: 5.157

2.  Preferential inhibition of 72- and 92-kDa gelatinases by tissue inhibitor of metalloproteinases-2.

Authors:  E W Howard; E C Bullen; M J Banda
Journal:  J Biol Chem       Date:  1991-07-15       Impact factor: 5.157

3.  Tumor promoter-stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: isolation and characterization of the enzyme from HT1080 tumor cells.

Authors:  U M Moll; G L Youngleib; K B Rosinski; J P Quigley
Journal:  Cancer Res       Date:  1990-10-01       Impact factor: 12.701

4.  Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines.

Authors:  P D Brown; A T Levy; I M Margulies; L A Liotta; W G Stetler-Stevenson
Journal:  Cancer Res       Date:  1990-10-01       Impact factor: 12.701

5.  Expression of metalloproteinase genes in human prostate cancer.

Authors:  M S Pajouh; R B Nagle; R Breathnach; J S Finch; M K Brawer; G T Bowden
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

6.  Identification of a serum- and phorbol ester-responsive element in the murine tissue inhibitor of metalloproteinase gene.

Authors:  C E Campbell; A M Flenniken; D Skup; B R Williams
Journal:  J Biol Chem       Date:  1991-04-15       Impact factor: 5.157

7.  Complete structure of the human gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92- and 72-kilodalton enzyme genes in HT-1080 cells.

Authors:  P Huhtala; A Tuuttila; L T Chow; J Lohi; J Keski-Oja; K Tryggvason
Journal:  J Biol Chem       Date:  1991-09-05       Impact factor: 5.157

8.  Binding of tissue inhibitor of metalloproteinases 2 to two distinct sites on human 72-kDa gelatinase. Identification of a stabilization site.

Authors:  E W Howard; M J Banda
Journal:  J Biol Chem       Date:  1991-09-25       Impact factor: 5.157

9.  Mutational analysis of the transin (rat stromelysin) autoinhibitor region demonstrates a role for residues surrounding the "cysteine switch".

Authors:  A J Park; L M Matrisian; A F Kells; R Pearson; Z Y Yuan; M Navre
Journal:  J Biol Chem       Date:  1991-01-25       Impact factor: 5.157

Review 10.  Type IV collagenases in tumor invasion and metastasis.

Authors:  W G Stetler-Stevenson
Journal:  Cancer Metastasis Rev       Date:  1990-12       Impact factor: 9.264

View more
  21 in total

1.  Classically activated macrophages use stable microtubules for matrix metalloproteinase-9 (MMP-9) secretion.

Authors:  Raed Hanania; He Song Sun; Kewei Xu; Sofia Pustylnik; Sujeeve Jeganathan; Rene E Harrison
Journal:  J Biol Chem       Date:  2012-01-23       Impact factor: 5.157

2.  Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue.

Authors:  Zhong Dong; R Daniel Bonfil; Sreenivasa Chinni; Xiyun Deng; J Carlos Trindade Filho; Margarida Bernardo; Ulka Vaishampayan; Mingxin Che; Bonnie F Sloane; Shijie Sheng; Rafael Fridman; Michael L Cher
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

3.  Dual targets for mouse mast cell protease-4 in mediating tissue damage in experimental bullous pemphigoid.

Authors:  Lan Lin; Eric Bankaitis; Lisa Heimbach; Ning Li; Magnus Abrink; Gunnar Pejler; Lijia An; Luis A Diaz; Zena Werb; Zhi Liu
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

Review 4.  The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis.

Authors:  T E VanMeter; H K Rooprai; M M Kibble; H L Fillmore; W C Broaddus; G J Pilkington
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

5.  Proteolytic action of kallikrein-related peptidase 7 produces unique active matrix metalloproteinase-9 lacking the C-terminal hemopexin domains.

Authors:  Vishnu C Ramani; Gur P Kaushal; Randy S Haun
Journal:  Biochim Biophys Acta       Date:  2011-05-17

6.  Circulating levels of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases during Japanese encephalitis virus infection.

Authors:  Vibha Shukla; Akhalesh Kumar Shakya; Mukti Shukla; Niraj Kumari; Narendra Krishnani; T N Dhole; Usha Kant Misra
Journal:  Virusdisease       Date:  2016-01-19

7.  The role of matrilysin (MMP-7) in leukaemia cell invasion.

Authors:  C C Lynch; S McDonnell
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

8.  In vivo matrix metalloproteinase-7 substrates identified in the left ventricle post-myocardial infarction using proteomics.

Authors:  Ying Ann Chiao; Rogelio Zamilpa; Elizabeth F Lopez; Qiuxia Dai; Gladys P Escobar; Kevin Hakala; Susan T Weintraub; Merry L Lindsey
Journal:  J Proteome Res       Date:  2010-05-07       Impact factor: 4.466

9.  Synergy between a plasminogen cascade and MMP-9 in autoimmune disease.

Authors:  Zhi Liu; Ning Li; Luis A Diaz; Michael Shipley; Robert M Senior; Zena Werb
Journal:  J Clin Invest       Date:  2005-04       Impact factor: 14.808

Review 10.  Matrix Metalloproteinases in Myocardial Infarction and Heart Failure.

Authors:  Kristine Y DeLeon-Pennell; Cesar A Meschiari; Mira Jung; Merry L Lindsey
Journal:  Prog Mol Biol Transl Sci       Date:  2017-03-18       Impact factor: 3.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.